These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7495107)

  • 1. Activation of the protein C pathway in acute sepsis.
    Alcaraz A; España F; Sánchez-Cuenca J; Zuazu I; Estellés A; Aznar J; Vicente V
    Thromb Res; 1995 Jul; 79(1):83-93. PubMed ID: 7495107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever.
    Vicente V; España F; Tabernero D; Estellés A; Aznar J; Hendl S; Griffin JH
    Blood; 1991 Jul; 78(2):416-22. PubMed ID: 1648982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states.
    España F; Gilabert J; Vicente V; Estellés A; Vazquez L; Hendl S; Aznar J
    Thromb Res; 1992 Jun; 66(5):499-508. PubMed ID: 1523606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
    Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
    España F; Hendl S; Gilabert J; Estellés A; Aznar J
    Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
    Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro complexes of activated protein C with two inhibitors in baboons.
    España F; Gruber A; Heeb MJ; Hanson SR; Harker LA; Griffin JH
    Blood; 1991 Apr; 77(8):1754-60. PubMed ID: 1849759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation.
    Mezzano D; España F; Panes O; Medina P; Pais E; Marshall G; Tagle R; Downey P; Caceres S; González F; Quiroga T; Pereira J
    Br J Haematol; 2001 Jun; 113(4):905-10. PubMed ID: 11442482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
    Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
    Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
    Minamikawa K; Wada H; Wakita Y; Ohiwa M; Tanigawa M; Deguchi K; Hiraoka N; Huzioka H; Nishioka J; Hayashi T
    Thromb Haemost; 1994 Feb; 71(2):192-4. PubMed ID: 7514816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
    Topper MJ; Prasse KW
    Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C anticoagulant system in patients with interstitial lung disease.
    Kobayashi H; Gabazza EC; Taguchi O; Wada H; Takeya H; Nishioka J; Yasui H; Kobayashi T; Hataji O; Suzuki K; Adachi Y
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1850-4. PubMed ID: 9620917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's.
    España F; Griffin JH
    Thromb Res; 1989 Sep; 55(6):671-82. PubMed ID: 2551066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
    Bremme K; Hamad RR; Berg E; Strandberg K; Stenflo J
    Thromb Res; 2012 Oct; 130(4):636-9. PubMed ID: 22154243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model.
    Hoogendoorn H; Nesheim ME; Giles AR
    Blood; 1990 Jun; 75(11):2164-71. PubMed ID: 2346780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes.
    Strandberg K; Bhiladvala P; Holm J; Stenflo J
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):503-10. PubMed ID: 11685037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.